{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T19:36:06Z","timestamp":1786822566245,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.msard.2021.102921","type":"journal-article","created":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T11:22:25Z","timestamp":1616930545000},"page":"102921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Neutrophil-lymphocyte ratio as a marker for disability and activity in multiple sclerosis"],"prefix":"10.1016","volume":"51","author":[{"given":"Rasha M.","family":"Fahmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bothina M.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Salah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed F.","family":"Elsaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahed","family":"Shehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2021.102921_bib0001","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1586\/14779072.2016.1154788","article-title":"Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update","volume":"14","author":"Afari","year":"2016","journal-title":"Expert Rev. Cardiovasc. Ther."},{"issue":"3","key":"10.1016\/j.msard.2021.102921_bib0002","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10072-014-1976-1","article-title":"The increase of carcinoembryonic antigen (CEA), high-sensitivity C-reactive protein, and neutrophil\/lymphocyte ratio in Parkinson's disease","volume":"36","author":"Akil","year":"2015","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.msard.2021.102921_bib0003","first-page":"1","article-title":"Relationship between neutrophil-to-lymphocyte ratio and stress in multiple sclerosis patients","volume":"11","author":"Al-Hussain","year":"2017","journal-title":"J. ClinDiagn. Res."},{"key":"10.1016\/j.msard.2021.102921_bib0004","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ana.410150307","article-title":"Medullasin activity in granulocytes of patients with multiple sclerosis","volume":"15","author":"Aoki","year":"1984","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2021.102921_bib0005","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.4049\/jimmunol.1400401","article-title":"Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases","volume":"193","author":"Aub\u00e9","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2021.102921_bib0006","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.msard.2017.10.009","article-title":"The neutrophil-to-lymphocyte ratio as disease activity marker in multiple sclerosis and optic neuritis","volume":"18","author":"Bisgaard","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2021.102921_bib0007","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00415-017-8676-8","article-title":"Changes in disability in people with multiple sclerosis: a 10-year prospective study","volume":"265","author":"Conradsson","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2021.102921_bib0008","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3390\/cells8101114","article-title":"The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis","volume":"8","author":"D'Amico","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.msard.2021.102921_bib0009","first-page":"700","article-title":"The clinical significance of the neutrophil-to-lymphocyte ratio in multiple sclerosis","volume":"126","author":"Demirci","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.msard.2021.102921_bib0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.7754\/Clin.Lab.2014.140927","article-title":"Neutrophil- and platelet-tolymphocyte ratios are correlated with disease activity in rheumatoid arthritis","volume":"61","author":"Fu","year":"2015","journal-title":"Clin. Lab."},{"key":"10.1016\/j.msard.2021.102921_bib0011","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1177\/1352458517703193","article-title":"No evident disease activity\u201d: the use of combined assessments in the management of patients with multiple sclerosis","volume":"23","author":"Giovannoni","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2021.102921_bib0012","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/ana.410180519","article-title":"Polymorphonuclear neutral protease activity in multiple sclerosis and other diseases","volume":"18","author":"Guarnieri","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2021.102921_bib0013","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcma.2015.08.010","article-title":"Is there an association between the expanded disability status scale and inflammatory markers in multiple sclerosis?","volume":"79","author":"Guzel","year":"2016","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.msard.2021.102921_bib0014","first-page":"1","article-title":"The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis","volume":"4","author":"Hasselbalch","year":"2018","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2021.102921_bib0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12883-019-1245-2","article-title":"The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis","volume":"19","author":"Hemond","year":"2019","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2021.102921_bib0016","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2021.102921_bib0017","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000341583","article-title":"The evaluation of neutrophil-lymphocyte ratio in Alzheimer's disease","volume":"34","author":"Kuyumcu","year":"2012","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.msard.2021.102921_bib0018","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1161\/STROKEAHA.116.013627","article-title":"Neutrophil-to-lymphocyte ratio predicts the outcome of acute intracerebral hemorrhage","volume":"47","author":"Lattanzi","year":"2016","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.msard.2021.102921_bib0019","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1586\/ern.10.7","article-title":"Environmental risk factors in multiple sclerosis","volume":"10","author":"Lauer","year":"2010","journal-title":"Expert. Rev. Neurother."},{"issue":"11","key":"10.1016\/j.msard.2021.102921_bib0020","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.4049\/jimmunol.161.11.6421","article-title":"Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis","volume":"161","author":"McColl","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2021.102921_bib0021","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jneuroim.2011.11.009","article-title":"Neutrophils in multiple sclerosis are characterized by a primed phenotype","volume":"242","author":"Naegele","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2021.102921_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0707-7","article-title":"Neutrophils in cancer: prognostic role and therapeutic strategies","volume":"16","author":"Ocana","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.msard.2021.102921_bib0023","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nri2015","article-title":"Systemic infections and inflammation affect chronic neurodegeneration","volume":"7","author":"Perry","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.msard.2021.102921_bib0024","first-page":"23","article-title":"The contribution of neutrophils to CNS autoimmunity","volume":"189","author":"Pierson","year":"2018","journal-title":"ClinImmunol"},{"key":"10.1016\/j.msard.2021.102921_bib0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1212\/01.WNL.0000167129.90918.f5","article-title":"High sensitivity measurement of CRP and disease progression in multiple sclerosis","volume":"65","author":"Soilu-H\u20acanninen","year":"2005","journal-title":"Neurol"},{"issue":"9","key":"10.1016\/j.msard.2021.102921_bib0026","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.1202613","article-title":"Neutrophils amplify autoimmune central nervous system infiltrates by maturing local APCs","volume":"191","author":"Steinbach","year":"2013","journal-title":"J. Immunol. Balt."},{"key":"10.1016\/j.msard.2021.102921_bib0027","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"1-2","key":"10.1016\/j.msard.2021.102921_bib0028","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jneuroim.2013.05.004","article-title":"Gender differences in circulating levels of neutrophil extracellular traps in serum of multiple sclerosis patients","volume":"261","author":"Tillack","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2021.102921_bib0029","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.3389\/fimmu.2018.02456","article-title":"Understanding the multifaceted role of neutrophils in cancer and autoimmune diseases","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2021.102921_bib0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ana.21640","article-title":"The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?","volume":"65","author":"Weiner","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2021.102921_bib0031","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3390\/jcm7120511","article-title":"The emerging role of neutrophil granulocytes in multiple sclerosis","volume":"7","author":"Woodberry","year":"2018","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.msard.2021.102921_bib0032","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2018.12.003","article-title":"Prediction of neutrophil-to-lymphocyte ratio in the diagnosis and progression of autoimmune encephalitis","volume":"694","author":"Zeng","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.msard.2021.102921_bib0033","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/09629359890857","article-title":"The immunoregulatory abilities of polymorphonuclear neutrophils in the course of multiple sclerosis","volume":"7","author":"Ziaber","year":"1998","journal-title":"Mediators Inflamm."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821001887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821001887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:54:34Z","timestamp":1761900874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821001887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":33,"alternative-id":["S2211034821001887"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.102921","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophil-lymphocyte ratio as a marker for disability and activity in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.102921","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102921"}}